News

RECENT PRESS RELEASES

We are pleased to share updates on our latest activities

November 22, 2024
ClexBio Secures Strategic Investments from GG 1978 and EQT Foundation to Advance Next-Generation Tissue Therapeutics
October 1, 2024
Anders Tuv Appointed to the ClexBio Board of Directors
September 25, 2024
ClexBio Wins a Place on the Impact/100 List for 2024
April 5, 2023
Renowned Harvard Professor Joins ClexBio Scientific Advisory Board
June 27, 2022
ClexBio collaborates with CSEM on automated manufacturing
July 20, 2021
ClexBio Oversubscribes USD 2.2M Round
December 4, 2020
ClexBio named Best Healthtech Startup